New Pharmaceutical Labeling Rules Proposed in Brazil
Friday, April 10th, 2009Brazil’s National Sanitary Vigilance Agency (ANVISA) is proposing changes in package labeling rules for pharmaceuticals sold in that country (as set out in ANVISA Resolution RDC 333/03) with a view to making pack labels more informative to consumers. For example, the proposals released for public consultation (until 11 May) would make medicines with a sedative […]
Brazil Proceeds with Compulsory Licensing of Antiretroviral Drug / Brasil continua com a licença compulsória de medicamento antiretroviral
Monday, October 6th, 2008Temas Observation: All developing nations have had the clear right to resort to compulsory licensing of pharmaceuticals since the adoption of the Doha Declaration by the World Trade Organization (WTO) in 2001. Brazil has long reserved this right under its own laws, although previously it has been hesitant to actually use the power, preferring instead […]